TTrialPathMatch Me to Trials
← Back to trials
RecruitingHematologic MalignanciesLymphomaMultiple Myeloma

DISCOVERY: Evaluating a Decision Support Tool for Adults Seen in Hematology/Oncology Clinics

Eligible age

60+ yrs

Accepts

All genders

Locations

1 state

Healthy volunteers

No

See if you qualify for this study

Answer a few quick questions about your location and health. Takes about a minute.

Check my eligibility →

About this study

The purpose of this study is to evaluate whether a novel decision support tool called PRIME (Preference Reporting to Improve Management and Experience), which combines values-elicitation with tailored feedback to patients and providers, improves patient-reported values-concordance of initial treatment decisions compared to usual care.

Sponsor: UNC Lineberger Comprehensive Cancer Center

You may qualify if…

  • ✓ 1. Written or verbal informed consent obtained to participate in the study and HIPAA authorization for the release of personal health information.
  • ✓ 2. Subjects are willing and able to comply with study procedures based on the judgment of the investigator.
  • ✓ 3. Age ≥ 60 years at the time of consent.
  • ✓ 4. New patient to either the hematologic malignancies clinic or the bone marrow transplant/cellular therapy clinic.

You may not qualify if…

  • ✕ All subjects meeting any of the exclusion criteria listed below at baseline will be excluded from study participation:
  • ✕ 1\. Dementia, altered mental status, or psychiatric condition that would prohibit the understanding or rendering of informed consent or participation in the intervention.

Where it's recruiting

North Carolina

Chapel Hill

Source: ClinicalTrials.gov · NCT06296368 · last updated 2026-08-14

DISCOVERY: Evaluating a Decision Support Tool for Adults Seen in Hemat · TrialPath